Colorectal cancer patients with liver metastases and severe hyperbilirubinemia: A consecutive series that explores the benefits and risks of chemotherapy

BACKGROUND: Do colorectal cancer patients with hyperbilirubinemia and liver metastases benefit from chemotherapy? METHODS/RESULTS: This study entailed a review of 3,019 consecutive patients with colorectal cancer. Within this cohort, 20 met the study’s a priori selection criteria, which included a n...

Descripción completa

Detalles Bibliográficos
Autores principales: Walia, Tamana, Quevedo, J Fernando, Hobday, Timothy J, Croghan, Gary, Jatoi, Aminah
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2643116/
https://www.ncbi.nlm.nih.gov/pubmed/19337442

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2643116/
https://www.ncbi.nlm.nih.gov/pubmed/19337442

Ejemplares similares